Document is current

Adalimumab plus MTX langzeitig wirksam

Crossref DOI link: https://doi.org/10.1007/s15002-014-0576-z

Published Online: 2014-04-14

Published Print: 2014-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy